Literature DB >> 18772145

Identification of proteins binding to E-Box/Ku86 sites and function of the tumor suppressor SAFB1 in transcriptional regulation of the human xanthine oxidoreductase gene.

Junji Lin1, Ping Xu, Patricia LaVallee, John R Hoidal.   

Abstract

The xanthine oxidoreductase gene (XOR) encodes an important source of reactive oxygen species and uric acid, and its expression is associated with various human diseases including several forms of cancer. We previously reported that basal human XOR (hXOR) expression is restricted or repressed by E-box and TATA-like elements and a cluster of transcriptional proteins, including AREB6-like proteins and DNA-dependent protein kinase (DNA-PK). We now demonstrate that the cluster contains the tumor suppressors SAFB1, BRG1, and SAF-A. We further demonstrate that SAFB1 silencing increases hXOR expression and that SAFB1 directly binds to the E-box. Multiple studies in vitro and in vivo including pulldown, immunoprecipitation and chromatin immunoprecipitation analyses indicate that SAFB1, Ku86, and BRG1 associate with each other. The results suggest that the SAFB1 complex binds to the hXOR promoter in a chromatin environment and plays a critical role in restricting hXOR expression via its direct interaction with the E-box, DNA-PK, and tumor suppressors. Moreover, we demonstrate that the cytokine, oncostatin M (OSM), induces the phosphorylation of SAFB1 and that the OSM-induced hXOR mRNA expression is significantly inhibited by silencing the DNA-PK catalytic subunit or SAFB1 expression. The present studies for the first time demonstrate that hXOR is a tumor suppressor-targeted gene and that the phosphorylation of SAFB1 is regulated by OSM, providing a molecular basis for understanding the role of SAFB1-regulated hXOR transcription in cytokine stimulation and tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18772145      PMCID: PMC2573066          DOI: 10.1074/jbc.M802076200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  79 in total

Review 1.  The role of oxidative stress in carcinogenesis.

Authors:  James E Klaunig; Lisa M Kamendulis
Journal:  Annu Rev Pharmacol Toxicol       Date:  2004       Impact factor: 13.820

2.  Role for BRG1 in cell cycle control and tumor suppression.

Authors:  Kristin B Hendricks; Frances Shanahan; Emma Lees
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

3.  Glutathione peroxidase, glutathione-S-transferase, catalase, xanthine oxidase, Cu-Zn superoxide dismutase activities, total glutathione, nitric oxide, and malondialdehyde levels in erythrocytes of patients with small cell and non-small cell lung cancer.

Authors:  Hasan Kaynar; Mehmet Meral; Hamdullah Turhan; Mustafa Keles; Gulnaz Celik; Fatih Akcay
Journal:  Cancer Lett       Date:  2005-01-08       Impact factor: 8.679

4.  Immunoprecipitation.

Authors:  J S Bonifacino; E C Dell'Angelica; T A Springer
Journal:  Curr Protoc Mol Biol       Date:  2001-05

5.  Xanthine oxidoreductase is a regulator of adipogenesis and PPARgamma activity.

Authors:  Kevin J Cheung; Iphigenia Tzameli; Pavlos Pissios; Ilsa Rovira; Oksana Gavrilova; Toshio Ohtsubo; Zhu Chen; Toren Finkel; Jeffrey S Flier; Jeffrey M Friedman
Journal:  Cell Metab       Date:  2007-02       Impact factor: 27.287

6.  Studies on milk xanthine oxidase. Some spectral and kinetic properties.

Authors:  V Massey; P E Brumby; H Komai
Journal:  J Biol Chem       Date:  1969-04-10       Impact factor: 5.157

7.  Oxidant stress and B vitamins status in patients with non-small cell lung cancer.

Authors:  Shih-Ming Tsao; Mei-Chin Yin; Wen-Hu Liu
Journal:  Nutr Cancer       Date:  2007       Impact factor: 2.900

8.  Characterization of proteins binding to E-box/Ku86 sites and function of Ku86 in transcriptional regulation of the human xanthine oxidoreductase gene.

Authors:  Ping Xu; Patricia A LaVallee; Jun J Lin; John R Hoidal
Journal:  J Biol Chem       Date:  2004-02-04       Impact factor: 5.157

9.  Uric acid promotes tumor immune rejection.

Authors:  De-En Hu; Alistair M Moore; Lindy L Thomsen; Kevin M Brindle
Journal:  Cancer Res       Date:  2004-08-01       Impact factor: 12.701

Review 10.  Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications.

Authors:  Cristine E Berry; Joshua M Hare
Journal:  J Physiol       Date:  2003-12-23       Impact factor: 5.182

View more
  10 in total

1.  Scaffold attachment factor B suppresses HIV-1 infection of CD4+ T cells by preventing binding of RNA polymerase II to HIV-1's long terminal repeat.

Authors:  Li Ma; Li Sun; Xia Jin; Si-Dong Xiong; Jian-Hua Wang
Journal:  J Biol Chem       Date:  2018-06-10       Impact factor: 5.157

2.  Acquired xanthine dehydrogenase expression shortens survival in patients with resected adenocarcinoma of lung.

Authors:  Hayato Konno; Yoshihiro Minamiya; Hajime Saito; Kazuhiro Imai; Yasushi Kawaharada; Satoru Motoyama; Jun-ichi Ogawa
Journal:  Tumour Biol       Date:  2012-06-08

3.  Drosophila SAF-B links the nuclear matrix, chromosomes, and transcriptional activity.

Authors:  Catalina Alfonso-Parra; Keith A Maggert
Journal:  PLoS One       Date:  2010-04-20       Impact factor: 3.240

4.  Weight Loss Mediated Reduction in Xanthine Oxidase Activity and Uric Acid Clearance in Adolescents with Severe Obesity.

Authors:  Harrison K Tam; Aaron S Kelly; Claudia K Fox; Brandon M Nathan; L'Aurelle A Johnson
Journal:  Child Obes       Date:  2016-03-15       Impact factor: 2.992

5.  Scaffold attachment factor B2 (SAFB2)-null mice reveal non-redundant functions of SAFB2 compared with its paralog, SAFB1.

Authors:  Shiming Jiang; Tiffany A Katz; Jason P Garee; Francesco J DeMayo; Adrian V Lee; Steffi Oesterreich
Journal:  Dis Model Mech       Date:  2015-06-18       Impact factor: 5.758

Review 6.  Xanthine oxidoreductase in cancer: more than a differentiation marker.

Authors:  Maria Giulia Battelli; Letizia Polito; Massimo Bortolotti; Andrea Bolognesi
Journal:  Cancer Med       Date:  2015-12-21       Impact factor: 4.452

7.  Xanthine dehydrogenase downregulation promotes TGFβ signaling and cancer stem cell-related gene expression in hepatocellular carcinoma.

Authors:  G-L Chen; T Ye; H-L Chen; Z-Y Zhao; W-Q Tang; L-S Wang; J-L Xia
Journal:  Oncogenesis       Date:  2017-09-25       Impact factor: 7.485

8.  Proteomics-Based Identification of the Molecular Signatures of Liver Tissues from Aged Rats following Eight Weeks of Medium-Intensity Exercise.

Authors:  Fanghui Li; Tao Li; Yanying Liu
Journal:  Oxid Med Cell Longev       Date:  2016-12-27       Impact factor: 6.543

9.  The Scaffold attachment factor b1 (Safb1) regulates myogenic differentiation by facilitating the transition of myogenic gene chromatin from a repressed to an activated state.

Authors:  J Manuel Hernández-Hernández; Chandrashekara Mallappa; Brian T Nasipak; Steffi Oesterreich; Anthony N Imbalzano
Journal:  Nucleic Acids Res       Date:  2013-04-22       Impact factor: 16.971

10.  Identification of potential biomarkers from microarray experiments using multiple criteria optimization.

Authors:  Matilde L Sánchez-Peña; Clara E Isaza; Jaileene Pérez-Morales; Cristina Rodríguez-Padilla; José M Castro; Mauricio Cabrera-Ríos
Journal:  Cancer Med       Date:  2013-02-27       Impact factor: 4.452

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.